Bayesian designs for phase I-II clinical trials /

Bayesian designs for phase I-II clinical trials / Ying Yuan, Hoang Q. Nguyen, Peter F. Thall.

Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same time, if promising preclinical results do not translate into a real treatment advance, it is important to determ...

Full description

Saved in:
Bibliographic Details
Online Access: Full Text (via Taylor & Francis)
Main Authors: Yuan, Ying (Professor of biostatistics) (Author), Nguyen, Hoang Q. (Author), Thall, Peter F. (Author)
Format: eBook
Language:English
Published: Boca Raton : Chapman & Hall/CRC, 2016.
Edition:1st.
Series:Chapman & Hall/CRC biostatistics series.
Subjects:
Clinical trials > Statistical methods.
Drugs > Testing > Statistical methods.
Bayesian statistical decision theory.

Internet

Full Text (via Taylor & Francis)

Online

Holdings details from Online
Call Number: R853.C55
R853.C55 Available

Similar Items